GLP-1 Use Increased Significantly Among Pediatric Patients With T2D in Past 5 Years | ADA 2025
From 2019 to 2024, GLP-1 prescriptions among pediatric patients with type 2 diabetes increased from 12.3% to 60.9%.
The Independent Pharmacist Championing Innovative, Patient-Centric Care
Amid the continuously evolving role of pharmacists in today’s health care landscape, independent owners like Amina Abubakar, PharmD, AAHIVP, are advancing the profession through innovation.
Obesity Medication Use Remains Low Among Children | ADA 2025
Researchers explored the prevalence of obesity-related complications and obesity medication use in US children and young adults with obesity.
The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies
Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
CDC Report Finds No Connection Between Thimerosal and Autism
Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s.
Procedure Shows Promise for Sustained Weight Loss After GLP-1 Therapy
Revita is a procedure that modifies duodenal dysfunction and restores metabolic health, according to Fractyl Health.
